Colossal Biosciences CEO Ben Lamm explains how ancient DNA, AI and CRISPR are helping scientists pursue de-extinction.
Scientists have made many advances using traditional CRISPR technology, especially in medicine, but they are now seeking ways ...
Controlling ribosomal RNA could help researchers target diseases driven by too little or too much protein production.
AI is rapidly reshaping biomedical research, but practitioners agree that AI’s success depends on more than advanced algorithms.
The future of cell and gene therapy may be defined less by discoveries and more by how the industry connects research and ...
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
According to Anthropic, scientists often spend a lot of time moving between research databases, coding tools, notebooks and high-performance computers., Technology & Science, Times Now ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Megan covers the intersection of ...
CRISPR Therapeutics is obviously a biopharma name -- but it's a unique one. Co-founder Emmanuelle Charpentier and her research collaborator Jennifer Doudna co-invented the CRISPR/Cas9 gene-editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results